The price seems to have reached a bottom after failing to break through a support level and ultimately rising higher in a sign of reversal to a new uptrend. The pattern formed over 6 hours and 0 minutes, which is a rough guide for how long it might take to reach the target price of 4.52 - 4.56... let some run for potential gap fill
Some big movement post-earnings, hoping for a bounce to around 6.21
Looks like it is a good time to get back in for a swing into the upcoming catalysts
Golden cross MA50 and MA200 as a support Going long
I'm long at $IMGN #IMGN (Falling wedge ) , NOTE: THIS IS BIOTECH COMPANY ,,i took a very tiny position .
My screener found this ticker. Has positive earnings (that's an understatement). Pulled back to an entry zone and the short volume is down. I will pick this up for 10-30% gains over the next 10-15 days as my target
IMGN pushed above POC and as biggest gainer after the open. Clear 1 hour chart, no resistance = long with trailing stop below 5 min bar.
Try to catch the near term momentum. Entry at the current level and adding position on possible pullback. Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation. Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
Contextual immersion trading strategy idea. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from...
Good tutes (Ra and Redmill) loaded recently - Has catalyst coming up this month and 2H, 2020 - My current avg is 4.77, planning on holding until the end of this year.
Possible entry level $7.21 or on pullback to $6.05 Target price $8.96 - $10 MAJOR DOWNTREND APPROACHING ImmunoGen (IMGN) Q4 results: Revenues: $44.9M (+235.1%). Net Income: $4.8M (+111.5%); EPS: $0.03 (+110.7%); Quick Assets: $176.2M (-32.8%). 2020 guidance: Revenues: $60M - 65M. Transition next generation anti-fol-ate receptor alpha ( ADC, IMGN151, to...
Let the run continue , lets see if it breaks the resistance mentioned in the chart.
$IMGN can be categorized as penny stock because its price per share is below $10 Given this fact this trade idea should be considered risky. But nothing in life that is worthy is free of risk, right? Since this is a volatile stock I would strongly suggest you should have a proper plan to execute it as a skilled surgeon In particular, you should set your Stop...
monitor the volume to determine if it will break the resistance or not.
Hi, Watch out for a reversal breakdown at ~ $5.25. A great opportunity to short sell.